Neuropharmacist faculty member’s project featured in MS Trust publication

11 July, 2019 | Posted in: ,

The MS Trust has just released its fifth issue of ‘MS in Practice’, a valuable resource outlining examples of positive practice and reviewing the practical application of new guidance for those with an interest in multiple sclerosis (MS). This particular issue features an article about the disease-modifying therapy (DMT) cost calculator, developed by neuropharmacist and […]

Continue Reading »

Latest patient experience findings are presented by the Neurological Alliance

9 July, 2019 | Posted in:

Today, the Neurological Alliance launched the report from their 2018/19 National Neurology Patient Experience Survey The report: Neuro Patience; was chosen with intended irony – the results show that the experience of people with neurological conditions remain poor. The main message in the report is that care and support for people with neurological conditions should […]

Continue Reading »

Mental Health Awareness Week

17 May, 2019 | Posted in:

Mental Health Awareness Week is coming to a close and this year’s focus has been body image. There has also been an abundance of focus on the commonality of mental health issues such as depression and anxiety as well as a renewed encouragement of our society to normalise mental health, to see it in as […]

Continue Reading »

The new vision for community pharmacy and its role in the NHS

14 May, 2019 | Posted in:

Real transformation will be needed to fulfil the NHS vision for community pharmacy and its role in healthcare provision for the future, say the Pharmaceutical Services Negotiating Committee (PSNC). Outlined in a video animation, the PSNC highlight the importance of pharmacy’s current work whilst detailing the transformation that community pharmacy is expected to undergo in […]

Continue Reading »

A new type of dementia is identified

8 May, 2019 | Posted in:

A team of researchers at the University of Kentucky have identified a new type of dementia, ‘LATE’ which until now may have been being wrongly diagnosed as Alzheimer’s disease. LATE, or limbic-predominant age-related TDP-43 encephalopathy, has been linked with the brain protein TDP-43, and may be the dementia type experienced by up to a third […]

Continue Reading »

Neurology Academy in the BJNN

3 May, 2019 | Posted in:

The British Journal for Neuroscience Nursing (BJNN) have just published a piece on the national drive to address unwanted variance in multiple sclerosis (MS) services. The project was initiated at ‘the Way Forward’ event last year when the MS Academy, part of Neurology Academy’s umbrella organisation, organised and hosted a lively two day conference full […]

Continue Reading »

The Neurology Academy’s expanding influence

1 May, 2019 | Posted in:

The Neurology Academy has come a long way in the past few years, ballooning from a single offering of MasterClasses in Parkinson’s to an extensive offering of educational courses spanning disease areas and tailored to different levels of learning. Recently that offering has diversified into cross-conditional topics like palliative care and neuropharmacy, and seen a […]

Continue Reading »

Early research suggests groundbreaking changes afoot for Parkinson’s

1 May, 2019 | Posted in:

Parkinson’s is a neurological condition that affects many elements of day to day functionality, changing a person’s experience of their everyday life. One of these elements is movement, with freezing, stumbling and falling all common symptoms of Parkinson’s. A recent pilot study in Canada has seen some radical changes in patient’s walking, resulting from electrical […]

Continue Reading »